| Serial Number | 97416718 |
| Word Mark | INVENTING NEW HOPE |
| Filing Date | Wednesday, May 18, 2022 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Monday, May 1, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 11, 2023 |
| Goods and Services | Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases; pharmaceutical preparations designed to deliver highly targeted therapeutic modulation to patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, gastrointestinal diseases, cardiovascular and metabolic diseases, and dermatologic diseases, genitourinary diseases, and orphan diseases; protein therapeutics, namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, dermatology, urology, gynecology, hepatology |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of treating cancer; medical research for use in oncology; pharmaceutical research for treating neuroendocrine tumors; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, circulatory, gastroenterological, digestive, hormonal, rheumatic, immune system, and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology, hepatology, laboratory medicine, clinical diagnostics, genetics and phenomics, pathology and forensics, proteomics, veterinary medicine and diagnostics, and basic research tools; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Monday, May 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Monday, May 1, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teon Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 |
| Party Name | Teon Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 |
| Event Date | Event Description |
| Tuesday, May 2, 2023 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Monday, May 1, 2023 | ABANDONMENT - AFTER PUBLICATION |
| Monday, April 17, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Tuesday, April 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 11, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, March 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 7, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, May 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, May 21, 2022 | NEW APPLICATION ENTERED |